TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · IEX Real-Time Price · USD

8.56

-0.09 (-1.04%)

At close: May 3, 2024, 4:00 PM

8.72

+0.16 (1.87%)

After-hours: May 3, 2024, 6:24 PM EDT

TScan Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	373	279	37	107	-	-
Market Cap Growth	-	647.03%	-65.10%	-	-	-
Enterprise Value	269	174	-2	-53	-28	-37
PE Ratio	-3.12	-3.12	-0.56	-2.20	-	-
PS Ratio	17.73	13.25	2.76	10.55	-	-
PB Ratio	2.47	1.85	0.38	0.67	-	-
P/FCF Ratio	-4.32	-4.32	-0.53	-1.82	-	-
P/OCF Ratio	-4.54	-4.54	-0.56	-2.20	-	-
EV/Sales Ratio	12.76	8.27	-0.13	-5.27	-25.76	-
EV/EBITDA Ratio	-2.17	-2.17	0.03	1.18	1.12	2.85
EV/EBIT Ratio	-2.04	-2.04	0.03	1.10	1.07	2.74
EV/FCF Ratio	-2.70	-2.70	0.02	0.91	3.85	2.72
Debt / Equity Ratio	0.61	0.61	0.86	0.04	-0.18	-0.29
Debt / EBITDA Ratio	-1.15	-1.15	-1.44	-0.13	-0.30	-0.37
Debt / FCF Ratio	-1.43	-1.43	-1.22	-0.10	-1.02	-0.35
Quick Ratio	6.61	6.61	7.23	7.80	2.03	17.68
Current Ratio	6.51	6.51	7.17	7.76	2.09	17.69
Asset Turnover	0.08	0.08	0.08	0.06	0.02	-
Interest Coverage	-22.73	-22.73	-55.31	-	-	-
Return on Equity (ROE)	-60.60%	-60.60%	-53.70%	-86.50%	87.70%	-
Return on Assets (ROA)	-33.90%	-33.90%	-38.70%	-29.30%	-52.70%	-
Return on Capital (ROIC)	-38.41%	-38.41%	-35.94%	-29.16%	74.89%	115.99%
Earnings Yield	-23.90%	-32.00%	-177.43%	-45.46%	-	-
FCF Yield	-17.28%	-23.13%	-189.50%	-54.81%	-	-
Buyback Yield / Dilution	-172.78%	-172.78%	-106.20%	-1173.20%	-137.87%	-
Total Shareholder Return	-172.78%	-172.78%	-106.20%	-1173.20%	-137.87%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).